Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A study identifies serum procalcitonin as a novel tumor biomarker for diagnosing and monitoring fibrolamellar hepatocellular carcinoma. This discovery could enhance early detection and treatment strategies for this rare liver cancer.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.